SCHEMBL20150506

SCHEMBL20150506

Cc1ccc2c3nn(-c4ccc(F)cc4)c(=O)c-3c[nH]c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 5/20 0.40
▸ POLB P06746 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ AURKA O14965 1/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ HAT1 O14929 1/20 0.37
▸ EP300 Q09472 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KAT2B Q92831 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150542 0.93 ALDH1A1 (0.45) KDM4EALDH1A1LMNAGAAHPGD
SCHEMBL20150526 0.88 GAA (0.43) POLBKDM4EALDH1A1LMNAGAA
SCHEMBL20150523 0.88 ALDH1A1 (0.43) KDM4EALDH1A1LMNAGAAHPGD
SCHEMBL20150498 0.86 CDK4 (0.43) POLBKDM4EALDH1A1LMNAGAA
SCHEMBL20150527 0.85 NPBWR1 (0.42) POLBKDM4EALDH1A1LMNAGAA
SCHEMBL20150539 0.84 NPBWR1 (0.43) TDO2KDM4EALDH1A1LMNAGAA
SCHEMBL20150525 0.84 NPC1 (0.47) POLBALDH1A1LMNAGAAMEN1
SCHEMBL18285375 0.84 NPSR1 (0.51) KDM4EALDH1A1LMNAHPGDMEN1
SCHEMBL20150553 0.84 TDO2 (0.42) TDO2KDM4EALDH1A1LMNAGAA
SCHEMBL20150543 0.83 LMNA (0.42) KDM4EALDH1A1LMNAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134698-A1 LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134698-A1 LIGANDS SELECTIVE TO ALPHA 6 SUBUNIT-CONTAINING GABAA RECEPTORS AND THEIR METHODS OF USE GABRA6, HTR6, GABRD TDO2 1382/4885POLB 4056/4885KDM4E 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback